Fabrication of a five-layer wound dressing containing chitosan-LL۳۷ peptide for the treatment of EB wounds and deep exudate patients
محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 29، شماره: 8
سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 45
فایل این مقاله در 12 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJBMS-29-8_009
تاریخ نمایه سازی: 14 مرداد 1405
چکیده مقاله:
Objective(s): This study aimed to develop and evaluate a multifunctional five-layer wound dressing that meets essential requirements for effective wound healing, including exudate absorption, antimicrobial activity, moisture retention, gas exchange, and non-damaging adhesion. The specific objective was to assess the antibacterial efficacy, biocompatibility, and wound-healing performance of a dressing incorporating chitosan–LL۳۷ nanoparticles (CS-LL۳۷ NPs).Materials and Methods: A five-layer wound dressing was fabricated, consisting of a silicone adhesive layer, a polyurethane (PU) foam layer embedded with CS-LL۳۷ NPs, a polypropylene diffusion layer, a cellulose-based retention layer, and a breathable, waterproof backing layer. The CS-LL۳۷ NPs were incorporated into the PU layer, and their antibacterial activity and cytotoxicity were evaluated in vitro. The dressing’s wound-healing performance, with and without CS-LL۳۷ NPs, was assessed in vivo in a female Wistar rat model and compared with that of a commercial dressing (Mepilex Border).Results: The developed five-layer dressing demonstrated effective exudate management, antimicrobial activity, and favorable healing conditions. In vivo results showed wound closure rates and histological outcomes comparable to those of the commercial dressing. The inclusion of CS-LL۳۷ NPs enhanced antibacterial performance without inducing significant cytotoxicity, indicating good biocompatibility.Conclusion: The prepared five-layer wound dressing exhibited healing performance comparable to a commercially available product. The incorporation of CS-LL۳۷ nanoparticles showed significant potential to improve treatment outcomes, particularly for exudative wounds, and may be a promising option for patients with chronic or fragile-skin conditions such as Epidermolysis Bullosa.
کلیدواژه ها:
نویسندگان
Morteza Rabiei
Nanobiotechnology Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
Mehrdad Mosazadeh Moghadam
Tissue Engineering and Regenerative Medicine Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
Hossein Derakhshankhah
Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
Ramezan Ali Taheri
Nanobiotechnology Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :